Health & Fitness

According to FutureWise analysis, the market for brain health supplements in 2023 is US$10.18 billion, and is expected to reach US$22.17 billion by 2031 at a CAGR of 10.20%. The global brain health supplements market is poised for substantial growth, projected to expand from approximately USD 8.6 billion in 2022 to over USD 23 billion by 2030. This trajectory represents a robust compound annual growth rate (CAGR) of around 13.3%. Several factors are driving this growth, including increasing consumer interest in cognitive enhancement, memory support, and overall mental well-being. Additionally, there is an increasing trend towards natural and plant-based nootropic products, which are gaining popularity among health-conscious consumers. Looking further ahead, longer-term forecasts indicate that the market will continue to thrive, with expectations of an increase from USD 9.8 billion in 2024 to approximately USD 22.2 billion by 2034, reflecting a steady CAGR of about 8.5%. This sustained ... Continue reading →

According to FutureWise analysis, the market for brain tumor treatment in 2023 is US$0.77 billion, and is expected to reach US$1.61 billion by 2031 at a CAGR of 9.60%. The world is witnessing an unsettling rise in brain tumor cases, with statistics from the American Society of Clinical Oncology (ASCO) revealing a more than 2% increase in diagnoses compared to 2019. In the United States alone, over 20,000 new cases of cancerous brain tumors have been identified. However, amidst this alarming trend, the field of oncology is experiencing rapid technological advancements that are poised to transform the brain tumor treatment market, projected to thrive in the years to come. FutureWise Market Research has released an in-depth report that examines the evolving Brain Tumor Treatment Market, highlighting key trends that will significantly impact its growth trajectory. This comprehensive study outlines vital details, including profitability trends, a thorough SWOT analysis, market share ... Continue reading →

According to FutureWise analysis, the market for breast augmentation in 2023 is US$1.33 billion, and is expected to reach US$3.74 billion by 2031 at a CAGR of 13.8%. The global breast augmentation market is projected to experience significant growth, with an estimated value of approximately USD 2.6 to 3.5 billion by the years 2024 to 2025. Forecasts indicate that this market could expand to around USD 5.7 to 5.9 billion by 2032 to 2034, reflecting a robust compound annual growth rate (CAGR) of approximately 6.7% to 7.9% during this period. Several factors are contributing to this upward trajectory. First, there is an increasing demand for cosmetic enhancement procedures as individuals seek to improve their aesthetic appearance and boost self-confidence. Additionally, there has been a noticeable rise in breast reconstruction surgeries, particularly following mastectomies performed as a treatment for breast cancer, which further amplifies the market’s growth potential. The ... Continue reading →

Medical emergencies can result in costing patients their lives, as any difficulties caused to them can lead to risking their well-being while they are in transit. With access to medically fitted airliners and advanced life-saving facilities, Panchmukhi delivers risk-free repatriation service that aims at serving the needs of the patients, taking them to their source destination without complications caused by our Best Patient Shifting Ambulance in Mumbai. Our air ambulance services are built upon the core principles of maintaining safety, creating a hassle-free journey, making the evacuation mission time efficient, and balancing the financial needs of the patients. Our medical jets are meticulously equipped with advanced life support facilities to ensure patient safety and comfort all along the way, keeping their health and well-being intact till the time Air Ambulance Services in Mumbai is in progress to the selected destination. Air Ambulance Services from Chennai are Meticulously ... Continue reading →

According to FutureWise analysis the market for antithrombin is expected to reach US$ 0.89 billion by 2031 at a CAGR of 4.30%. Antithrombin is a key glycoprotein produced in the liver that plays a crucial role in the body’s haemostatic system. Its main function is to regulate the coagulation cascade, thereby preventing excessive clot formation. As a serine protease inhibitor, antithrombin neutralizes essential enzymes involved in coagulation, particularly thrombin (factor IIa) and factor Xa. By forming inhibitory complexes with these enzymes, antithrombin effectively hinders the conversion of fibrinogen to fibrin, which is necessary for the formation of stable blood clots. Genetic deficiencies in antithrombin can lead to an increased risk of thrombotic disorders, underlining its vital role in maintaining the balance between bleeding and clotting. In clinical practice, antithrombin is integral to the prevention and treatment of thrombotic events such as deep vein thrombosis ... Continue reading →

According to FutureWise analysis the market for antiviral drugs in 2023 was US$ 61.42 billion, and is expected to reach US$ 84.84 billion by 2031 at a CAGR of 4.12%. Antiviral drugs represent a specialized category of medications designed to combat viral infections. Unlike bacteria and other microorganisms, viruses cannot reproduce or perform metabolic processes independently; they rely on host cells for replication and dissemination. Antiviral drugs work by targeting key phases of the viral replication cycle. This can involve inhibiting the entry of viruses into host cells, disrupting the replication of viral genomes, or blocking the assembly and release of new viral particles, known as virions. One prominent category of antiviral drugs is nucleoside/nucleotide analogs. These compounds imitate the structure of natural nucleotides and interfere with the synthesis of viral DNA or RNA, thereby impeding viral replication. Notable examples of nucleoside analogs include ... Continue reading →

According to FutureWise analysis the market for Aortic Aneurysm in 2023 was US$ 5.21 billion, and is expected to reach US$ 11.86 billion by 2031 at a CAGR of 10.80%. An aortic aneurysm is a critical medical condition characterized by a weakened and bulging segment in the wall of the aorta, the largest blood vessel in the body. The aorta plays a vital role in transporting oxygenated blood from the heart to various tissues and organs. When a portion of the aorta weakens, it can progressively expand and develop into an aneurysm. These aneurysms can occur in different sections of the aorta, with the abdominal and thoracic areas being the most common sites. The development of an aortic aneurysm can be influenced by several factors, including high blood pressure, atherosclerosis (the buildup of fatty deposits in the arteries), smoking, genetic factors, and certain connective tissue disorders. Additionally, age and gender are relevant risk factors, as the incidence of aortic aneurysms tends ... Continue reading →

According to FutureWise analysis the market for aortic aneurysm repair in 2023 was US$ 2.4 billion, and is expected to reach US$ 4.48 billion by 2031 at a CAGR of 8.12%. An aortic aneurysm is characterized by a balloon-like bulging of the aorta, which is the large artery responsible for carrying blood from the heart throughout the chest and body. Aortic aneurysms can lead to serious complications such as dissection or rupture. Dissection takes place when the layers of an artery wall start to come apart because of the pressure from blood flow, leading to blood seeping in between them. A rupture, on the other hand, is a more critical event where the aneurysm bursts, causing internal bleeding. Both dissection and rupture are significant contributors to fatalities associated with aortic aneurysms. Healthcare professionals may recommend surgical intervention based on various factors like the underlying cause, size, and rate of growth of the aneurysm, especially in cases of rupture or ... Continue reading →

According to FutureWise analysis, the market for breast biopsy in 2023 is US$1.60 billion, and is expected to reach US$3.54 billion by 2031 at a CAGR of 10.40%. The global breast biopsy market is anticipated to experience steady growth over the next several years, projected to expand from approximately USD 2.6 billion in 2024 to around USD 5.2 billion by 2037. This represents a compound annual growth rate (CAGR) of roughly 6.9%. Short-term forecasts further underscore this positive trend, with market values expected to increase from an estimated USD 2.38 billion in 2025 to USD 3.26 billion by 2030. Several key factors are propelling this growth. Firstly, the rising incidence of breast cancer worldwide is a significant driver, with statistics indicating that early detection through biopsy can improve patient outcomes. Additionally, there is a growing awareness surrounding breast health and the importance of regular screening, which is encouraging more women to undergo biopsy procedures. ... Continue reading →

Cancer is a condition characterized by uncontrolled cell growth, with approximately 100 different types recognized. Each type is classified based on the specific type of cell it affects. Breast cancer is the most common type of cancer in women, although it is uncommon in men. It is also a leading cause of death among elderly women. The most prevalent forms of breast cancer include ductal carcinoma in situ (DCIS) and lobular carcinoma. DCIS, also known as intraductal carcinoma, is found in the linings of the milk ducts, which are thin tubes transporting milk from the breast lobules to the nipple. Lobular carcinoma originates in the lobules, also known as milk glands. The majority of breast cancer diagnoses are invasive ductal carcinoma, which begins in the milk duct and penetrates through its wall, allowing the cancer to invade surrounding fatty breast tissue. This type of cancer can also spread to other parts of the body through the bloodstream. Breast cancer therapy involves various ... Continue reading →